# Do GLP-1 Drugs Help Trigger Finger? What the Studies Measured | Buy This GLP

What studies found about GLP-1 drugs, trigger finger treatment, surgery after steroid injection and recovery after release.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/do-glp1-drugs-help-trigger-finger
Updated: 2026-11-15
Published: 2026-09-16

[← Research](https://buythisglp.com/research)

Evidence

# Do GLP-1 Drugs Help Trigger Finger? What the Studies Measured

Three studies looked at different questions, including the chance of surgery after a steroid injection and recovery after release.

Editorial profile: [Wesley Jenkins](https://buythisglp.com/authors/wesley-jenkins)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20265 min readUpdated November 2026

GLP-1 users against non-users, three cohorts · trigger finger diagnosis · fewer in users · Stump · surgery after a steroid shot · 10.6% vs 11.9% at 1 yr · Khan · release after diagnosis · more in users · Stump · pain a year after release · 21.6% vs 16.9% · Dameron · repeat release at 1 year · 11.4% vs 9.5% · Dameron · Each study followed a different group of patients.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   The studies followed different groups and cannot establish whether GLP-1 drugs prevent or treat trigger finger.
-   Among people with type 2 diabetes who had a steroid injection, 10.6% of GLP-1 users and 11.9% of matched nonusers had surgery within one year.
-   One database study found more recorded pain and repeat surgery among people with GLP-1 exposure around the time of surgery. That exposure could begin before or after the operation.

Trigger finger causes a finger or thumb to catch or lock when a tendon has trouble gliding through its sheath [\[4\]](https://buythisglp.com/research/do-glp1-drugs-help-trigger-finger#ref-4). The tendon problem is distinct from [diabetic peripheral neuropathy](https://buythisglp.com/research/do-glp1-drugs-help-diabetic-neuropathy), which affects nerves and sensation. Usual care can include splinting or a corticosteroid injection. If symptoms persist, a surgeon may consider releasing the A1 pulley to make room for the tendon to glide [\[4\]](https://buythisglp.com/research/do-glp1-drugs-help-trigger-finger#ref-4).

## What happened after a steroid injection?

One health records study matched 5,863 GLP-1 users with 5,863 nonusers. All had type 2 diabetes and received an initial corticosteroid injection for trigger finger. At one year, 10.6% of users and 11.9% of nonusers had a release (RR 0.89, 95% CI 0.81 to 0.99). At two years, 14.2% and 15.7% had surgery, respectively (RR 0.90, 95% CI 0.83 to 0.98). The difference at six months was statistically inconclusive [\[1\]](https://buythisglp.com/research/do-glp1-drugs-help-trigger-finger#ref-1).

A second study of people with type 2 diabetes found fewer trigger finger diagnoses among GLP-1 users overall and more release procedures among users who already had trigger finger[\[2\]](https://buythisglp.com/research/do-glp1-drugs-help-trigger-finger#ref-2). That group was defined by a trigger finger diagnosis. The first study followed patients specifically after a steroid injection, so the two results answer different questions.

## What happened after surgery?

In a third records study, each matched group included 4,283 patients who had a release. At one year, patients with GLP-1 exposure had more recorded pain (21.6% vs. 16.9%), scarring (2.3% vs. 1.5%), wound complications (2.3% vs. 1.4%), and repeat releases (11.4% vs. 9.5%) [\[3\]](https://buythisglp.com/research/do-glp1-drugs-help-trigger-finger#ref-3). Infection rates were statistically similar.

Researchers counted GLP-1 exposure during the year before or after surgery. Because some patients could have had complications before starting the drug, this matters when interpreting [the evidence on wound healing with GLP-1 drugs](https://buythisglp.com/research/do-glp1-drugs-slow-wound-healing). The second study used preoperative exposure and found similar rates of selected complications within 90 days, including surgical site infection, joint stiffness and wound separation[\[2\]](https://buythisglp.com/research/do-glp1-drugs-help-trigger-finger#ref-2).

If you take a GLP-1 drug and plan to have surgery, discuss [how to manage it before the procedure](https://buythisglp.com/research/do-you-have-to-stop-a-glp1-before-surgery) with your surgical team. These trigger finger studies did not test whether pausing medication changes surgical outcomes.

## Frequently asked

Do GLP-1 drugs help trigger finger?

The available records studies do not establish that GLP-1 drugs treat trigger finger. One study found fewer release procedures after a steroid injection among users with type 2 diabetes, but other studies followed people at different points in their care.

Can these studies tell me whether to stop my GLP-1 before surgery?

No. The studies did not test medication pauses. One study counted use in the year before or after release. Discuss medication timing with your surgical team.

## Sources

1.  \[1\] Khan AA, et al. (2026). GLP-1 Receptor Agonist Use and A1 Pulley Release After Corticosteroid Injection for Trigger Finger in Type 2 Diabetes Hand (New York, N.Y.). [PMID 42678052](https://pubmed.ncbi.nlm.nih.gov/42678052/)
2.  \[2\] Stump K, et al. (2026). Relationship between glucagon-like peptide-1 receptor agonist use and incidence of trigger finger in patients with type 2 diabetes Hand surgery & rehabilitation. [PMID 41619807](https://pubmed.ncbi.nlm.nih.gov/41619807/)
3.  \[3\] Dameron LS, et al. (2026). The Influence of Glucagon-like Peptide-1 Receptor Agonists on Outcomes Following Trigger Finger Release Journal of hand surgery global online. [PMID 41657744](https://pubmed.ncbi.nlm.nih.gov/41657744/)
4.  \[4\] Gil JA, Hresko AM, Weiss AC (2020). Current Concepts in the Management of Trigger Finger in Adults Journal of the American Academy of Orthopaedic Surgeons. [PMID 32732655](https://pubmed.ncbi.nlm.nih.gov/32732655/)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
